BEONE MEDICINES REPORTS SUSTAINED SURVIVAL BENEFIT WITH TEVIMBRA-ZIIHERA COMBINATION IN FIRST-LINE HER2+ GASTROESOPHAGEAL CANCER

Reuters · 1d ago

Please log in to view news